CeliacDx Consult

Pathology Review of Celiac Disease Test Results

The CeliacDx Consult is a pathology review of your GlutenID^TM Test and Celiac Disease Panel antibody results. It is designed for sharing with your healthcare provider as a guide to next steps in the diagnosis and treatment of celiac disease. Biopsy results, symptoms, and family history can also be included based on your answers to a quick questionnaire provided by CeliacDx pathologists.

If you think you have celiac disease, prepare for a healthcare appointment by letting CeliacDx pathologists organize your test data with the CeliacDx Consult. This ensures you will have answers to questions at your fingertips to help clarify the root cause of your symptoms.

Ready to request your CDx Consult?

Order your consult

Share test reports

Receive your consult

$100.00

HOW IT WORKS

Celiac Results Interpretation Made Easy With The CeliacDx Consult

CELIAC DISEASE

Sorting It All Out

Celiac disease diagnosis is essentially putting the pieces of a puzzle together to get a complete picture. No single test alone can make the diagnosis. Thus the most complete approach includes comprehensive analysis of symptoms, family history, genetics, antibody testing and small bowel biopsy.

A good place to start is with genetic testing for the celiac risk genes HLA-DQ2 and HLA-DQ8. Negative genetic results can rule out celiac disease so antibody testing is not necessary. If genetics show increased risk, then antibody testing is the next step with small bowel biopsy confirmation if needed.

The CeliacDx Consult provides expert pathology review of celiac test results in context of symptoms, family history, and dietary gluten. Please note the CeliacDx Consult is designed to share with your healthcare provider to facilitate diagnosis and treatment of celiac disease. The CeliacDx consult will not provide a diagnosis of celiac disease or any other medical condition.

Targeted Genomics offers the following CeliacDx testing services for celiac disease: The CeliacDx Consult from CeliacDx PLLC, The Celiac Disease Panel antibody test through QuestHealth.com, and The GlutenID^TM celiac genetic health risk (GHR) test. The CeliacDx testing services are designed to give consumers access to laboratory testing and pathology consultation. The CeliacDx testing services are not diagnostic of celiac disease or any other condition. CeliacDx testing service users should consult with a licensed healthcare provider before making any changes to their diet or lifestyle. The GlutenID Test uses qualitative genotyping to detect clinically relevant variants in genomic DNA collected from saliva cells for the purpose of reporting and interpreting celiac genetic health risk (GHR). This test provides genetic risk information about specific genetic variants but does not report on a User’s entire genetic profile. Other companies offering a celiac genetic risk test may detect different genetic variants for the same disease so the User may receive different results from another company. This test is not intended to diagnose celiac disease. Other factors such as lifestyle and ethnicity may affect celiac disease risk. Some people may feel anxious about getting genetic test results. This is normal. Talk with your healthcare provider or a genetic counselor about genetic testing. The celiac GHR report describes if a person has variants associated with a higher risk of developing celiac disease but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Warnings & Limitations: This test does not include variants in other genes linked to celiac disease and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact celiac risk. The GlutenID^TM test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. The intended use of the GlutenID^TM Test does not include prenatal testing, cancer predisposition, pharmacogenomic assessment, or determination of autosomal dominant genetic variants. For important information and limitations regarding genetic health risk reports, visit https://targeted-genomics.com/wp-content/uploads/2022/07/GlutenID-Package-Insert-for-website_Rev5.pdf.